Professor
Kanazawa University
Kanazawa, Ishikawa, Japan
Ikumi Tamai, Ph.D., Professor. Department of Membrane Transport and Biopharmaceutics, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Japan.
Dr. Tamai’s research has focused on membrane transporters for drugs and nutrients/endogenous compounds starting in 1980's. He has contributed to the research on the role of P-glycoprotein as the BBB firstly published in 1992, molecular cloning and physiological and pharmacological roles of OCTNs since 1997, and the roles of OATP transporters for intestinal absorption as well as hepatic disposition of drugs since 2000. Along with these studies, more recently he has been studying effect of food-derived micro-vesicles that contain microRNAs and proteins, which is expected to be applied to oral delivery of macromolecular drugs. Also, he is studying the roles of transporters in drug-induced liver and kidney toxicities by establishing new methods such as 3D-cultured renal proximal tubular epithelial cells and novel hepatocytes culture model, icHep that will be presented in this meeting. He served as a council member of ISSX and JSSX and Editor-in-Chief of Drug Metabolism and Pharmacokinetics (DMPK), and is currently an associate editor of Biopharmaceutics and Drug Disposition (BDD) and Pharmaceutical Research.
Wednesday, October 25, 2023
9:30 AM – 10:00 AM ET